Regenlabusa Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Regenlabusa

Access the complete profile.

Regenlabusa Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	812 Personal & Laundry Services
Address	140 58th St Ste 2a Bldg A Brooklyn, NY 11220

Note: Revenues for privately held companies are statistical evaluations.


Regenlabusa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Regenlabusa's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Regenlabusa is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Regenlabusa Annual Revenue and Growth Rate

Regenlabusa	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Regenlabusa's revenues are gauged from an analysis of company filings.

Regenlabusa's Income Statement (based on Industry Averages)

Regenlabusa P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Regenlabusa is developing and marketing. Regenlabusa doesn't have any recent trademark applications, indicating Regenlabusa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CELLULARWOUND Medical apparatus and instruments for use in mesotherapy, esthetic, and pain management procedures; surgical and medical apparatus and instruments for use in dental, orthopedic, cosmetic, esthetic, and ophthalmological surgery; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; surgical instruments, namely, glass tubes for separating biological tissues; medical and surgical apparatus and instruments for use in general surgery; Surgical, medical and veterinary apparatus and instruments, including apparatus and instruments for autologous blood treatment, blood collection apparatus and instruments, apparatus and instruments for blood separation, apparatus and instruments for bone marrow separation, apparatus and instruments for centrifugation of blood, apparatus and instruments for filtering blood, and coagulation instruments; Surgical, medical and veterinary apparatus and instruments for the production of platelet rich plasma membranes, bone marrow concentrate, and platelet rich plasma in combination with hyaluronic acid	08/07/2023
GENDERFREE Medicated cosmetics; Medicated anti-wrinkle cream for skin care; medicated serums for the treatment of skin, body, face and hair; medicated lotions for the treatment of skin, body, face and hair	08/29/2022
LUBRIMOTION Medicated cosmetics; Medicated anti-wrinkle cream for skin care; Medicated serums for treatment of face, eye, body and hair; Medicated lotions for face, body, scalp, hair, skin, and sunburn; Orthopedic articles, namely, syringes sold filled with hyaluronic acid, syringes sold filled with hyaluronic acid and lidocaine, for the treatment of osteoarthritis	08/29/2022

See all trademarks and details in the Full Report.

Market Share of Regenlabusa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Regenlabusa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Regenlabusa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
HEAT MAKE SENSE	Brooklyn, NY	100
THRIFTWAY SERVICES CORP / BBP VENTURES	Brooklyn, NY	82
BRIGHT PHARMACY	Brooklyn, NY	16
REGENLABUSA	Brooklyn, NY	13
DONNAMAX	Brooklyn, NY	10
EMUNA D/B/A NAVAR PHARMACY	Brooklyn, NY	3

Future Competition: Regenlabusa's Fastest Growing Competitors

These companies are in the same general field as Regenlabusa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)